Press release content from Globe Newswire. The AP news staff was not involved in its creation.
SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent .
SpringWorks Therapeutics, Inc.February 25, 2021 GMT
- Reported Interim Data from Phase 2b ReNeu Trial of Mirdametinib in NF1-PN Demonstrating Encouraging Clinical Activity and Tolerability in the First 20 Adult Patients Enrolled - -
- Continued to Strengthen Nirogacestat Patent Portfolio -
- Multiple Data Readouts Expected in 2021 Across
Pipeline, Including Topline Data from Phase 3 DeFi Trial in Desmoid Tumors and Initial Nirogacestat BCMA Combination Data -
ADVERTISEMENT
- Ended 2020 with $561.8 Million in Cash, Cash Equivalents and Marketable Securities -
10 Best Biotech Stocks to Invest In According To Billionaire Biotech Hedge Fund
Joseph Edelman is one of the most successful biotech hedge fund portfolio managers since he founded Perceptive Advisors in 1999, with the strategy of generating gains by investing in small and mid-cap biotechnology stocks. The assets under management of Edelman’s hedge fund soared from $6 million in 1999 to almost $6.85 billion in the last two decades.
Its flagship fund, Perceptive Life Sciences Fund, specializes in investing money in small- and mid-cap biotech companies. The fund reported losses in 2002, 2008 and 2018 when the broader biotech index fell at a high double-digit rate. Biotech stocks have a little correlation to the broader stock market because these stocks make moves on speculations and events such as trial results and FDA approval.
Annual Changes To The Nasdaq Biotechnology Index Date
11/12/2020
Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq Biotechnology Index (Nasdaq: NBI), which will become effective prior to market open on Monday, December 21, 2020.
The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® (Nasdaq®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB).
The following 100 securities will be added to the Index:
EXCHANGE